Cocrystal Pharma (COCP) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free COCP Stock Alerts $1.73 -0.02 (-1.14%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEnrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenzafinance.yahoo.com - May 1 at 8:21 AMEnrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenzaglobenewswire.com - May 1 at 8:00 AMCOCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision Leads to Valuation of $6 Per Share…finance.yahoo.com - April 23 at 5:42 PMAnalysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and Icecure Medical (ICCM)markets.businessinsider.com - April 5 at 3:36 AMCOCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023msn.com - March 28 at 3:06 PMCocrystal Pharma, Inc.: Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programsfinanznachrichten.de - March 28 at 11:16 AMRecap: Cocrystal Pharma Q4 Earningsbenzinga.com - March 28 at 11:16 AMCocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programsglobenewswire.com - March 28 at 8:00 AMCocrystal Pharma, Inc.: Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza Afinanznachrichten.de - March 20 at 6:39 PMCocrystal Pharma Receives Pre-IND Feedback Regarding CC-42344 - Quick Factsmarkets.businessinsider.com - March 19 at 1:01 PMCocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza Aglobenewswire.com - March 19 at 8:00 AMCocrystal Pharma Inc (COCP)investing.com - February 24 at 9:38 AMCOCP: Cocrystal Pharma provides updates on its clinical programs.finance.yahoo.com - February 20 at 3:25 PMCocrystal Pharma Inc COCPmorningstar.com - February 11 at 10:55 PMCocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidatesfinance.yahoo.com - January 4 at 8:41 AMCocrystal Pharma Stock (NASDAQ:COCP), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 26 at 3:48 PMCocrystal Pharma Stock (NASDAQ:COCP) Dividends: History, Yield and Datesbenzinga.com - December 26 at 3:48 PMCocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza Afinance.yahoo.com - December 6 at 9:42 AMCocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coastfinance.yahoo.com - November 29 at 8:28 AMCocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023finance.yahoo.com - November 27 at 8:26 AMCocrystal Pharma Stock (NASDAQ:COCP) Earnings Dates and Earning Callsbenzinga.com - November 14 at 4:35 PMCOCP: Cocrystal Pharma reports 3rd quarter financial results and provides updates on clinical trials.msn.com - November 14 at 4:35 PMRecap: Cocrystal Pharma Q3 Earningsbenzinga.com - November 13 at 9:53 AMCocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programsfinance.yahoo.com - November 13 at 8:32 AMCocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coastfinance.yahoo.com - November 9 at 8:45 AMBuy Rating Issued for Cocrystal Pharma Amid Advancements in Influenza and Coronavirus Treatmentsmarkets.businessinsider.com - November 3 at 11:14 PMCocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344finance.yahoo.com - October 31 at 8:56 AMHC Wainwright & Co. Reiterates Cocrystal Pharma (COCP) Buy Recommendationmsn.com - October 5 at 3:34 PMCOCP: Cocrystal Pharma doses 1st subjects in the important CDI-988 clinical trial.finance.yahoo.com - October 2 at 6:48 PMCOCP: Cocrystal Pharma reports 2nd quarter 2023 financial results and provides updates on drug pipeline.finance.yahoo.com - August 16 at 5:50 PMAnalyst Ratings for Cocrystal Pharmamarkets.businessinsider.com - August 15 at 3:26 PMCocrystal Pharma (COCP) Receives a Buy from H.C. Wainwrightmarkets.businessinsider.com - August 15 at 8:59 AMNoble Financial Keeps Their Buy Rating on Cocrystal Pharma (COCP)markets.businessinsider.com - August 15 at 8:59 AMCocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programsfinance.yahoo.com - August 14 at 5:35 PMAnalysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Tyra Bioscience (TYRA)markets.businessinsider.com - August 11 at 4:04 PMCocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Leadfinance.yahoo.com - August 8 at 8:12 AMCocrystal Pharma Receives HREC Approval to Initiate Phase 1 Study to Evaluate Oral Broad-Spectrum Coronavirus 3CL Protease Inhibitor CDI-988finance.yahoo.com - May 31 at 8:16 AMHC Wainwright & Co. Maintains Cocrystal Pharma (COCP) Buy Recommendationmsn.com - May 24 at 7:39 PMH.C. Wainwright Keeps Their Buy Rating on Cocrystal Pharma (COCP)markets.businessinsider.com - May 24 at 8:43 AMCOCP: Cocrystal Pharma reports 1st quarter 2023 financial results and provides updates on drug pipeline.finance.yahoo.com - May 17 at 3:08 PMCocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programsfinance.yahoo.com - May 15 at 9:30 AMCocrystal Pharma Presents New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conferencefinance.yahoo.com - May 4 at 4:52 PMCocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directorsfinance.yahoo.com - April 24 at 8:09 AMCocrystal Pharma to Present New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conferencefinance.yahoo.com - April 18 at 9:41 AMCocrystal Pharma Inc (COCP) Up 15.54% in Premarket Tradingbenzinga.com - April 12 at 7:28 PMWhy Cocrystal Pharma Shares Are Trading Higher Todaymsn.com - April 10 at 6:29 PMCocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - April 10 at 9:15 AMH.C. Wainwright Sticks to Its Buy Rating for Cocrystal Pharma (COCP)markets.businessinsider.com - April 5 at 9:58 AMNoble Financial Sticks to Their Buy Rating for Cocrystal Pharma (COCP)markets.businessinsider.com - March 30 at 8:58 AMCocrystal Pharma Reports 2022 Financial Results and Provides Updates on its Antiviral Drug Development Programsfinance.yahoo.com - March 29 at 11:07 AM Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! COCP Media Mentions By Week COCP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COCP News Sentiment▼0.920.58▲Average Medical News Sentiment COCP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COCP Articles This Week▼30▲COCP Articles Average Week Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TNXP News Today VAXX News Today TLPH News Today AYTU News Today VBIV News Today EDSA News Today NERV News Today HUGE News Today VINC News Today INDP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COCP) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICElon to Transform U.S. Economy? Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
